Venom

Følg
Illustration of Amazonian scorpion venom research showing potential against breast cancer, with lab equipment and scientists.
Bilde generert av AI

Amazonian scorpion venom peptide shows paclitaxel-like action against breast cancer cells in lab tests

Rapportert av AI Bilde generert av AI Faktasjekket

Researchers in Brazil have identified a molecule in the venom of the Amazonian scorpion Brotheas amazonicus that kills breast cancer cells in vitro with effects similar to the chemotherapy drug paclitaxel, according to FAPESP. Early tests indicate the peptide chiefly induces necrosis, underscoring venoms’ promise as a source of biopharmaceuticals.

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis